Founder/CEO Joe Dusseldorp, leading reconstructive surgeon, aims to help the millions of patients worldwide with spasticity who at present have to make some compromising choices in search of relief from constant muscle over-contraction. “You can either permanently sever the nerve controlling the muscle, or disable the muscle for a period of months through locally injecting Botox or drip feeding Baclofen. The issue with those treatments is you can’t turn them off for a minute to restore some muscle tone to help you put on your clothes or get out of your wheelchair.”
Syncricity is building implants that are orders of magnitude cheaper and smaller than traditional neuromodulation systems. A series of them can be inserted easily alongside targeted peripheral nerves, then powered and controlled from outside the body by a battery powered, body worn controller. The nerve blocking signal does not damage the nerves and has already been proven by multiple scientific teams to be effective in stopping muscle contraction.
Recent advancements in wireless power transfer technology are enabling this next generation of implants - the size of a grain of rice - to be implanted as deep as 5 cm or more. Patient and customer research shows a strong desire for this solution over incumbents. Health economics show an average lifetime saving over incumbents. Syncricity has gained significant traction in innovation competitions and grants, and has established a credible set of design and advisory partners.
Syncricity was the major winner of the 2024 BBFH Challenge, a Healthcare Startup Competition offered by IDE Group. Competing with medtech innovators across Australia, the Netherlands and Colombia, we are honoured to receive a prize package valued at up to $40,000 in design, development, and commercialisation services from IDE Group.
Syncricity was the National Bionics Innovation Prize Winner in the Bionics Challenge 2022 conducted by Bionics Queensland. You can watch the pitch now in the video to the left.
Read more about how the team aims to accomplish their mission in this article in Hospital and Healthcare Magazine.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.